ANTI-PD-L1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

SINGLE VARIABLE DOMAIN ANTIBODY TARGETING HUMAN PROGRAMMED DEATH LIGAND 1 (PD-L1) AND DERIVATIVE THEREOF

MODIFIED J-CHAIN

ANTI-CD47 ANTIBODIES AND METHODS OF USE

Antigen Binding Proteins

ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES WITH SINGLE BINDING ARMS AND USES THEREOF

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

TARGET TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE

COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34

Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody

Methods of Treatment Using Anti-IL-17A/F Antibodies

ANTIGEN BINDING PROTEIN

Broadly-Neutralizing HIV Antibodies

NOVEL MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF

FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE

Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody

ANTIBODIES BINDING TO CD3

STABILIZED BETA-CORONAVIRUS ANTIGENS

IMMUNOGLOBULIN MEDIATED VACCINATIONS AGAINST VIRAL DISEASES

MDR immunogen

COMPOSITIONS AND METHODS FOR ENHANCING DONOR OLIGONUCLEOTIDE-BASED GENE EDITING

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof

STABLE FORMULATION FOR RECOMBINANT ANTI-PD-1 MONOCLONAL ANTIBODY

CD44-MODULATING COMPOSITIONS FOR METHODS FOR TREATING CANCERS AND ASCITES

DENDRITIC CELL ACTIVATING THERAPY AS AN ADJUNCT TO RADIATION THERAPY

ANTIBODIES AGAINST OX-40 AND USES THEREOF

ANTI-CD137 ANTIGEN-BINDING MOLECULE FOR USE IN CANCER TREATMENT

IFNGR binding synthetic cytokines and methods of use

METHOD OF TREATING OR PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME

ST2 ANTIGEN BINDING PROTEIN

Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody

B7-H3 DIRECTED ANTIBODY DRUG CONJUGATES

ANTI-VISTA ANTIBODIES AND USES THEREOF

Monoclonal Antibodies to Programmed Death 1 (PD-1)

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules

Treatment Of Lung Disease Based Upon Stratification Of Polygenic Score Relating To Response To A Therapeutic Agent

TL1A PATIENT SELECTION METHODS, SYSTEMS, AND DEVICES

Anti-Angiopoietin-2 Antibodies and Uses Thereof

ANTI-MUTANT CALRETICULIN (CALR) ANTIBODIES AND USES THEREOF

NUCLEIC ACID ENCODED ANTIBODY MIXTURES

FC-EPSILON CAR

SEPARATION MOIETIES AND METHODS OF USE THEREOF

RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

Muscle targeting complexes and uses thereof for treating dystrophinopathies

Dosing parameters for CD47 targeting therapies to hematologic malignancies

METHODS FOR THE TREATMENT OF IDIOPATHIC ORBITAL INFLAMMATION AND RELATED CONDITIONS

PEPTIDE IMMUNOGENS AND FORMULATIONS THEREOF TARGETING MEMBRANE-BOUND IgE FOR TREATMENT OF IgE MEDIATED ALLERGIC DISEASES

Animal Models and Therapeutic Molecules

Methods for assessing risk of developing a viral disease using a genetic test

Anti-TMPRSS2 antibodies and antigen-binding fragments

HEPARANASE-NEUTRALIZING A54 MONOCLONAL ANTIBODY

ANTI-PROTEIN S SINGLE-DOMAIN ANTIBODIES AND POLYPEPTIDES COMPRISING THEREOF

ANTIBODY CONSTRUCTS BINDING 4-1BB AND FOLATE RECEPTOR ALPHA AND USES THEREOF

ANTIBODIES TO CD70

ANTI CD25 FC GAMMA RECEPTOR BISPECIFIC ANTIBODIES FOR TUMOR SPECIFIC CELL DEPLETION

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLAMMATION

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

Anti-PD-1 Antibodies

ANTIBODY AGAINST NECTIN-4 AND APPLICATION THEREOF

Modified immunoglobulins for targeting amyloid deposits

Humanized anti-Tau(PS422) antibodies and methods of use

HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 413

HUMANIZED ANTIBODY SPECIFIC TO BACILLUS ANTHRACIS PROTECTIVE ANTIGEN AND PREPARATION METHOD THEREOF

Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2

ANTIBODY BINDING TO HEPATITIS B VIRUS SURFACE ANTIGEN AND APPLICATION OF ANTIBODY

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

ANTIBODY FORMULATIONS

TARGETED DRUG DELIVERY TO SITES OF INTRAVASCULAR OCCLUSION

Animal Models and Therapeutic Molecules

ENHANCING BLOOD-BRAIN BARRIER DRUG TRANSPORT BY TARGETING ENDOGENOUS REGULATORS

BISPECIFIC ANTIBODIES BINDING TO 5T4 AND CD3 FOR USE IN TREATMENT OF CANCER

Chimeric canine anti-CD20 antibody

ANTI-CD70 ANTIBODY AND APPLICATION THEREOF

CANCER TREATMENT

ANTI-PDL1 x EGFR BISPECIFIC ANTIBODY

IN SITU THIOL-MALEIMIDE CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY

ANTIBODY OF IL-11 AND USE THEREOF

Anti-p53 antibodies

High concentration anti-C5 antibody formulations

ANTI-C3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES

ANTIBODIES SPECIFICALLY RECOGNIZING C5A AND USES THEREOF

ANTI-TAU ANTIBODIES

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLUENZA

T-cell modulatory multimeric polypeptides and methods of use thereof

FUSION PROTEIN COMPRISING ANTI-LAG-3 ANTIBODY AND IL-2, AND USE THEREOF

COMPOSITION FOR OVERCOMING RESISTANCE TO EGFR-TARGETING AGENT

Anti-transferrin receptor antibody and uses thereof

ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF

BINDING PROTEINS AND METHODS OF USE THEREOF

PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CANCER

CANCER THERAPEUTIC AGENT

IMMUNITY ENHANCING AGENT FOR CANCER BY ALLERGIN-1 ANTAGONIST

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

AMH AND/OR INHIBIN B AS A BIOMARKER FOR AN EFFECT OF A TREATMENT TO IMPROVE MALE FERTILITY

CELL PENETRATING PROTEIN-ANTIBODY CONJUGATES AND METHODS OF USE

Humanized Anti-GPC-1 Antibody

THERAPEUTIC DRUG FOR CARCINOMATOUS PERITONITIS

ILT7 BINDING MOLECULES AND METHODS OF USING THE SAME

Methods and compositions comprising purified recombinant polypeptides

PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR PREVENTION OF A C5-RELATED DISEASE AND A METHOD FOR TREATING OR PREVENTING A C5-RELATED DISEASE

Anti-spike glycoprotein antibodies and the therapeutic use thereof

MULTIMERS FOR VIRAL STRAIN EVOLUTION

Selectively altering microbiota for immune modulation

METHOD AND COMPOSITION FOR ENHANCING CANCER TREATMENT EFFICACY OF BACTERIA EXTRACELLULAR VESICLES

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

POLYPEPTIDES, PROTEIN COMPLEXES AND METHOD FOR MAKING SAME

Antibody that binds ErbB-2 and ErbB-3

HEAVY CHAIN ANTIBODIES BINDING TO PSMA

CONDITIONALLY ACTIVE ANTI-CD46 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF

COMBINATION THERAPY INVOLVING ANTI-CD39 ANTIBODIES AND ANTI-PD-1 OR ANTI-PD-L1 ANTIBODIES

ANTI-OX40 ANTIBODY AND USES THEREOF

ANTI-BCMA ANTIBODY, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF

Agonistic anti-IL-2R antibodies and methods of use

STABLE ANTIBODY VARIABLE DOMAIN FRAMEWORK COMBINATIONS

MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2

ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER

ENGINEERED IMMUNOGLOBULINS

Humanized Anti-Human CD89 Antibodies and Uses Thereof

A BISPECIFIC ANTI-PD-L1/VEGF ANTIBODY AND USES THEREOF

TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA

ADAPTER MOLECULES TO RE-DIRECT CAR T CELLS TO AN ANTIGEN OF INTEREST

SLAMF7 CARS

ANTI-PAR2 ANTIBODIES AND USES THEREOF

CANINE ANTIBODY VARIANTS

Treating refractory migraine

MODULATING IMMUNE RESPONSE

BROADLY NEUTRALIZING AND POTENT ANTIBODIES AGAINST HIV

HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2)

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF SARS-COV-2 VIRUS INFECTION

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND THEIR USE IN CAR-T CELLS

NON-INTUITIVE COMBINATION OF DRUG DELIVERY CARRIERS OF THE SAME DRUG FOR SYNERGISTIC GROWTH DELAY OF SOLID TUMORS

NIR-conjugated tumor-specific antibodies and uses thereof

MULTIFUNCTIONAL IMMUNOTHERAPEUTIC MONOCLONAL ANTIBODY COMPLEXES AND CONJUGATES

Anti-human MSLN antibody and MSLN-targeting immune effector cell

Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy

ANTI-GD2 SADA CONJUGATES AND USES THEREOF

TARGETED MODIFIED IL-1 FAMILY MEMBERS

COMBINATION THERAPY USING A LIV1-ADC AND A CHEMOTHERAPEUTIC

TROPHOBLAST CELL-SURFACE ANTIGEN-2 (TROP-2) ANTIBODIES

ANTI-CD93 CONSTRUCTS AND USES THEREOF

TREATMENT OF ATOPIC DERMATITIS

ANTIGEN-BINDING PROTEINS THAT ANTAGONIZE LEPTIN RECEPTOR

ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES

TARGETED BINDING AGENTS AGAINST B7-H1

Binding Members to PD-L1

ANTI-PD1 ANTIBODIES AND USES THEREOF

BTLA ANTIBODIES

BIFUNCTIONAL PROTEIN AGAINST PD-1 AND TGF-BETA

MONOCLONAL ANTIBODIES AGAINST LILRB1 FOR DIAGNOSTIC AND THERAPEUTIC USE

CONDITIONALLY ACTIVE ANTI-NECTIN-4 ANTIBODIES

TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

HUMANIZED CD19 ANTIBODY AND USE THEREOF

SINGLE-DOMAIN ANTIBODIES DIRECTED AGAINST LILRB2

ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF

STABLE ANTI-CLEVER-1 ANTIBODY FORMULATION

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS

TREATMENT OF HIDRADENITIS SUPPURATIVA

MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS USING SAME

Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof

Compositions and methods for the removal of biofilms

Compositions and methods for TCR reprogramming using fusion proteins

Fusion molecules of CTLA4 and IL-15

TNF-alpha immunoconjugate therapy for the treatment of brain tumors

CYTOTOXIC BENZODIAZEPINE DERIVATIVES

ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER

GENE EDITING METHODS AND COMPOSITIONS FOR ELIMINATING RISK OF JC VIRUS ACTIVATION AND PML (PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY) DURING IMMUNOSUPPRESSIVE THERAPY

METHOD FOR TREATING PD-L1 EXPRESSING CANCER

ANTI-TUMOR COMPOSITION

Hematopoietic Stem Cell Engraftment

Methods of permeabilizing the blood brain barrier

Automated heart valve manufacturing

ENZYME-MEDIATED DEPLETION OF ADENOSINE AND/OR METHYLTHIOADENOSINE

Enhanced Chimeric Antigen Receptor Cells in Hypoxic Tumor Microenvironment

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS

TREATMENT OF FOOD ALLERGY USING ANTI-IGE ANTIBODIES

ANTI-C5 ANTIBODIES AND USES THEREOF

AGONIST ANTI-CD40 ANTIBODIES

AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING LUNG CANCERS

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

NEW ANTIBODY BLOCKING HUMAN FCGRIIIA AND FCGRIIIB

SELECTION OF RESPONDERS FOR ANTI-BTN3A TREATMENT

Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to treat cancer

ONCOLYTIC VIRUS COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

Anti-alpha-synuclein antibodies and uses thereof

METHODS AND COMPOSITIONS RELATED TO NEUTRALIZING ANTIBODIES AGAINST HUMAN CORONAVIRUS

SARS-COV2 NEUTRALIZING SINGLE DOMAIN ANTIBODY CONSTRUCTS

CORONA VIRUS BINDERS

BIFUNCTIONAL BRIDGING COMPOSITIONS FOR VIRAL TRANSDUCTION

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY

ANTI-HUMAN NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) ANTIBODIES

ANTI-FXI/FXIA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF

COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS

ANTI-CD73 ANTIBODY AND USE THEREOF

THERAPEUTIC DRUG FOR POLYCYTHEMIA

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

ANTI-ST2 ANTIBODY AND APPLICATION THEREOF

ANTIBODIES WITH MODIFIED AFFINITY TO FCRN THAT PROMOTE ANTIGEN CLEARANCE

ANTI-PD-1/CD40 BISPECIFIC ANTIBODIES AND USES THEREOF

BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS

FABS-IN-TANDEM IMMUNOGLOBULIN AND USES THEREOF

TSP-1 INHIBITORS FOR THE TREATMENT OF AGED, ATROPHIED OR DYSTROPHIED MUSCLE

ROR1 ANTIBODIES

HUMANIZED ANTIBODIES DIRECTED AGAINST KCNK9

ANTIBODIES TO INTERLEUKIN-1BETA AND USES THEREOF

IL-1BETA BINDING ANTIBODIES FOR USE IN TREATING CANCER

METHOD OF TREATING EARLY STAGE DUPUYTREN'S DISEASE

GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN CANCER THERAPY

Anti-S100A4 antibodies for the treatment of systemic sclerosis

ANTIBODIES SPECIFICALLY RECOGNIZING NERVE GROWTH FACTOR AND USES THEREOF

ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE

DOSING OF POLYOMAVIRUS NEUTRALIZING ANTIBODIES

T-cell modulatory multimeric polypeptides and methods of use thereof

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

TREATMENT WITH ANTI-VEGF ANTIBODIES

PHARMACEUTICAL COMPOSITIONS WITH ANTI-RANKL ANTIBODIES, CALCIUM AND VITAMIN D

HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR

IMMUNOMODULATING TREATMENTS OF BODY CAVITIES

DPP3 IN PATIENTS INFECTED WITH CORONAVIRUS

ENGINEERED VIRUS

TRISPECIFIC ANTIBODIES SPECIFIC FOR HER2 AND A BLOOD BRAIN BARRIER RECEPTOR AND METHODS OF USE

FIXED DOSING OF HER ANTIBODIES

ERIBULIN ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

ANTI-HUMAN TLR7 ANTIBODY

Antibodies binding TNFR2 and uses thereof

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

EARLY INTERVENTION METHODS TO PREVENT OR AMELIORATE TOXICITY

BISPECIFIC FC MOLECULES

Methods of treatment by targeting VCAM1 and MAEA

ANTI-B7-H3 ANTIBODY AND PREPARATION THEREFOR AND USE THEREOF

USE OF ANTI-PD-1 ANTIBODY IN TREATING NEUROENDOCRINE TUMORS

ANTI-CD3 ANTIBODIES AND USES THEREOF

C-KIT antibodies and method for treating cancer with such

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

IL-23 Specific Antibodies for the Treatment of Systemic Sclerosis

TREATMENT AND PREVENTION OF DISEASE CAUSED BY TYPE IV COLLAGEN DYSFUNCTION

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES

SERUM ALBUMIN BINDING NANOBODY COMPOSITIONS AND METHODS FOR USING THE SAME

Antibody neutralizing human respiratory syncytial virus

DOUBLE PAYLOAD CANCER THERAPEUTICS

SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES

METHODS OF IMAGING USING MULTIPLE IMAGING AGENTS

CYSTEINE LINKED NANOBODY DIMERS

Monoclonal Antibody Against Human Siglec-9 and Use For Immunotherapy

Cancer Neoepitopes

IMPROVED PEPTIDE VACCINE

TRIAGING METHOD USING CELL FREE NUCLEOSOME LEVELS

MODIFIED ONCOLYTIC VIRUS

BINDING MOLECULES WITH MODIFIED J-CHAIN

ANTI-VWF D'D3 SINGLE-DOMAIN ANTIBODIES AND POLYPEPTIDES COMPRISING THEREOF

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

CD 163 ANTIBODIES OR BINDING PROTEINS

Treatment of diabetes mellitus

CHIMERIC ANTIGEN RECEPTOR CAR OR CAR CONSTRUCT TARGETING BCMA AND CD19 AND APPLICATION THEREOF

Antibody Variants with Improved Pharmacokinetic Properties

COMPOSITION FOR PREVENTING OR ALLEVIATING CELLULAR SENESCENCE

Anti-human interleukin-4 receptor alpha antibody and preparation method and application thereof

Anti-CSF1R Molecules and Use Thereof

Selective Picture-Based Encryption of Video Streams

MULTISPECIFIC ANTIBODY

Chimeric antigen receptors targeting GPRC5D

METHODS FOR MODULATING INTESTINE CELLS OR TISSUE FUNCTION

ANTI-MDR1 ANTIBODIES AND USES THEREOF

Engineered anti-IL-2 antibodies

Methods and Treatment Involving Antibodies to IL-18

Humanised anti-n-truncated amyloid β monoclonal antibody

POTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2, GENERATION AND USES THEREOF

IMMUNOSTIMULATORY MULTIMERIC BINDING MOLECULES

BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF

ANTI-PD-L1 ANTIBODIES

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

Polyspecific Binding Molecules and their use in Cell Therapy

ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT

COMBINATION COMPOSITIONS FOR IMMUNOTHERAPY

PHARMACOKINETIC & PHARMACODYNAMIC MODEL FOR DETERMINING EFFECTIVE DOSE OF ANTI-TICAGRELOR ANTIBODY

Methods and compositions for antibody to high affinity receptor for IgE

NOVEL ANTI-PAD4 ANTIBODY

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING PEDIATRIC HEREDITARY ANGIOEDEMA ATTACK

ENGINEERED ANTI-HER2 BISPECIFIC PROTEINS

Anti-LY6H antibodies and antibody drug conjugates

EPITOPE REGION-BRIDGING BIPARATOPIC ANTIBODY AND METHOD FOR PRODUCING SAME

DOSING REGIMEN OF ANTI-CD27 ANTIBODIES FOR TREATMENT OF CANCER

Antibody binding specifically to CD40 and use thereof

Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels

METHOD OF TREATING DISEASES USING AN IL-17 RECEPTOR ANTIBODY FORMULATION

COMPOSITIONS AND METHODS FOR TREATING NONINFLAMMATORY PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS

ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF

Antibodies Binding to Vista at Acidic pH